Trupanion (TRUP) Resumen de Acciones
Trupanion, Inc. junto con sus filiales, ofrece seguros médicos para perros y gatos mediante suscripción en Estados Unidos, Canadá, Europa continental y Australia. Saber más
| Puntuación del snowflake | |
|---|---|
| Valoración | 0/6 |
| Crecimiento futuro | 1/6 |
| Rendimiento pasado | 2/6 |
| Salud financiera | 4/6 |
| Dividendos | 0/6 |
TRUP Community Fair Values
Create NarrativeSee what 7 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Competidores de Trupanion, Inc.
Historial de precios y rendimiento
| Precios históricos de las acciones | |
|---|---|
| Precio actual de la acción | US$25.35 |
| Máximo en las últimas 52 semanas | US$57.89 |
| Mínimo de 52 semanas | US$21.16 |
| Beta | 1.42 |
| Cambio en 1 mes | 16.87% |
| Variación en 3 meses | -0.39% |
| Cambio de 1 año | -54.73% |
| Variación en 3 años | 28.81% |
| Variación en 5 años | -78.05% |
| Variación desde la OPV | 122.37% |
Noticias y actualizaciones recientes
Actualización de narrativa • Jun 16
TRUP: Recalibrated Expectations And Improved Margins Will Support Long-Term Repricing
Trupanion's analyst price target has been reduced by $7 to $45. Analysts attribute the revision to updated assumptions around revenue growth, profit margins and future P/E multiples.
Actualización de narrativa • Jun 01
TRUP: Rebased P/E And Margin Assumptions Will Support Long Term Upside
Trupanion's analyst price target is updated from $46.25 to $39.75 as analysts factor in refreshed assumptions around discount rates, revenue growth, profit margins, and future P/E expectations, reflected in recent Street research cuts from BofA, Cantor Fitzgerald, and Stifel. Analyst Commentary Recent Street research indicates that the lower price targets are tied to refreshed assumptions around discount rates, revenue growth, profit margins, and future P/E expectations.Seeking Alpha • May 26
Trupanion: The Stock Has De-Rated, But The Problems Haven't
Summary Trupanion maintains respectable revenue growth and record subscription margins, but growth is driven by price increases, not pet enrollment. Pet enrollment continues at a sluggish 5% annual rate, while customer acquisition costs and veterinary inflation outpace revenue growth, pressuring unit economics. Management's digital-first product launch targets younger demographics but carries high execution risk and is unlikely to materially impact 2026 results. Despite a strong balance sheet and lower valuation, TRUP's core growth and competitive challenges justify maintaining a sell rating. Read the full article on Seeking AlphaActualización de narrativa • May 13
TRUP: Recalibrated Expectations And Higher Future P/E Will Support Long-Term Repricing
Analysts have lowered their fair value estimate for Trupanion from $63.00 to $52.00, citing updated price targets from several firms along with adjustments to discount rates, revenue growth, profit margin assumptions, and the stock's future P/E multiple. Analyst Commentary Recent Street research on Trupanion has centered on revised price targets that reflect updated assumptions for growth, margins, and valuation multiples.Recent updates
Actualización de narrativa • Jun 16
TRUP: Recalibrated Expectations And Improved Margins Will Support Long-Term Repricing
Trupanion's analyst price target has been reduced by $7 to $45. Analysts attribute the revision to updated assumptions around revenue growth, profit margins and future P/E multiples.Actualización de narrativa • Jun 01
TRUP: Rebased P/E And Margin Assumptions Will Support Long Term Upside
Trupanion's analyst price target is updated from $46.25 to $39.75 as analysts factor in refreshed assumptions around discount rates, revenue growth, profit margins, and future P/E expectations, reflected in recent Street research cuts from BofA, Cantor Fitzgerald, and Stifel. Analyst Commentary Recent Street research indicates that the lower price targets are tied to refreshed assumptions around discount rates, revenue growth, profit margins, and future P/E expectations.Seeking Alpha • May 26
Trupanion: The Stock Has De-Rated, But The Problems Haven't
Summary Trupanion maintains respectable revenue growth and record subscription margins, but growth is driven by price increases, not pet enrollment. Pet enrollment continues at a sluggish 5% annual rate, while customer acquisition costs and veterinary inflation outpace revenue growth, pressuring unit economics. Management's digital-first product launch targets younger demographics but carries high execution risk and is unlikely to materially impact 2026 results. Despite a strong balance sheet and lower valuation, TRUP's core growth and competitive challenges justify maintaining a sell rating. Read the full article on Seeking AlphaActualización de narrativa • May 13
TRUP: Recalibrated Expectations And Higher Future P/E Will Support Long-Term Repricing
Analysts have lowered their fair value estimate for Trupanion from $63.00 to $52.00, citing updated price targets from several firms along with adjustments to discount rates, revenue growth, profit margin assumptions, and the stock's future P/E multiple. Analyst Commentary Recent Street research on Trupanion has centered on revised price targets that reflect updated assumptions for growth, margins, and valuation multiples.
Actualización de narrativa • Apr 22
TRUP: Clustered Price Cuts And P/E Reset Will Shape Future Returns
Trupanion's updated analyst price target has been reduced by a mid single digit dollar amount, with analysts pointing to recently lowered targets from several firms, alongside only modest tweaks to long term revenue growth, profit margin and future P/E assumptions. Analyst Commentary Recent Street research on Trupanion has centered on a series of price target reductions, with cuts ranging from low single digit dollar amounts up to a $15 move.Actualización de narrativa • Apr 08
TRUP: Revised P/E And Margin Assumptions Will Support Future Earnings Power
Trupanion's updated analyst price target has shifted from $42.00 to $31.00 as analysts factor in different assumptions for future revenue growth, profitability and P/E expectations following several recent target cuts across the Street. Analyst Commentary Recent Street research on Trupanion has centered on a series of lower price targets, with several bearish analysts trimming their expectations within a relatively short time frame.Actualización de narrativa • Mar 25
TRUP: Rebased P/E Expectations Will Support Long Term Upside Potential
Narrative Update on Trupanion The analyst price target for Trupanion has been reduced by a combined $26, as several firms revisited their models and pricing assumptions. This led to a lower implied future P/E while keeping the fair value estimate steady at $46.25.Actualización de narrativa • Mar 10
TRUP: Reset Expectations And Higher Future P/E Will Drive Long-Term Repricing
Trupanion's updated $63.0 analyst price target reflects modestly tempered expectations for revenue growth and profit margin, with analysts citing recent target reductions from several firms as they reassess the stock's risk and return trade off. Analyst Commentary Recent Street research on Trupanion clusters around lower price targets, but the tone is not uniformly negative.Actualización de narrativa • Feb 24
TRUP: Long Term Profitability Assumptions Will Support Future Upside Potential
Analysts have reduced their Trupanion price targets by approximately $10 to $46.25, reflecting updated views on fair value, discount rate, revenue growth, profit margin, and future P/E assumptions following recent research updates from multiple firms. Analyst Commentary Recent research updates on Trupanion point to a mix of optimism about the long term opportunity and caution about the execution and valuation risks in the near term.Actualización de narrativa • Feb 09
TRUP: Higher Future P/E Assumptions Will Support A Stronger Long-Term Repricing
Analysts have reduced their Trupanion price target by about $4 to US$63, citing updated assumptions around fair value, discount rate, revenue growth, profit margin and future P/E as the key drivers of the change. Analyst Commentary Bullish analysts are refining their views on Trupanion as they revisit key valuation inputs such as fair value estimates, discount rates, revenue assumptions, profit margins and future P/E levels.Actualización de narrativa • Jan 25
TRUP: Revised P/E Assumptions Will Support Long Term Earnings Power
Analysts have reduced their price targets on Trupanion by $8, citing updated assumptions for revenue growth, profit margin and future P/E, which modestly adjust the risk and return profile they see for the stock. Analyst Commentary Bearish analysts cutting their price targets by $8 are signaling a more cautious stance on Trupanion, driven by updated assumptions for revenue growth, profit margin and future P/E.Actualización de narrativa • Jan 11
TRUP: Future Margin Gains And Share Discipline Will Support Long Term Earnings Power
Analysts are maintaining a US$42.00 price target for Trupanion, with small adjustments to revenue growth, profit margin assumptions and a lower future P/E helping to fine tune their outlook rather than reset it. What's in the News Trupanion reported that, between July 1 and September 30, 2025, it did not repurchase any shares under its existing program and has completed total buybacks of 95,021 shares for US$5.75 million, representing 0.23% of shares under the buyback announced on April 30, 2021 (company filing).Actualización de narrativa • Dec 27
TRUP: Future Margin Expansion Will Support Strengthening Long Term Earnings Power
Analysts have modestly maintained their price target on Trupanion at approximately $42.00, citing slightly stronger expectations for revenue growth, incremental profit margin improvement, and a marginally lower future price to earnings multiple that together support the current valuation stance. What's in the News Updated full year 2025 guidance now calls for total revenue of $1.433 billion to $1.439 billion and subscription revenue of $986 million to $989 million, implying roughly 15% year over year subscription growth at the midpoint (company guidance).Actualización de narrativa • Dec 12
TRUP: Future Margin Recovery Will Support Strengthening Long Term Earnings Power
Analysts have modestly reduced their price target on Trupanion from 45.00 dollars to 42.00 dollars. This reflects more conservative assumptions for revenue growth, profit margins, and valuation multiples, despite a largely unchanged risk outlook.Actualización de narrativa • Aug 10
Increasing Pet Ownership And Data Analytics Will Expand Market
The consensus price target for Trupanion has increased to $59.67 as analysts assign a higher future P/E multiple despite a modest decline in net profit margin, signaling greater optimism about its growth prospects. Valuation Changes Summary of Valuation Changes for Trupanion The Consensus Analyst Price Target has significantly risen from $53.00 to $59.67.Nueva narrativa • May 27
Global Expansion And Pricing Precision Will Shape Pet Markets
Enhanced pricing strategies, technology upgrades, and disciplined underwriting are driving margin expansion, higher operational efficiency, and more sustainable long-term earnings.Artículo de análisis • May 13
Trupanion, Inc. (NASDAQ:TRUP) Looks Just Right With A 26% Price Jump
Trupanion, Inc. ( NASDAQ:TRUP ) shareholders are no doubt pleased to see that the share price has bounced 26% in the...Artículo de análisis • Feb 16
There's Reason For Concern Over Trupanion, Inc.'s (NASDAQ:TRUP) Price
When close to half the companies in the Insurance industry in the United States have price-to-sales ratios (or "P/S...Seeking Alpha • Dec 13
Trupanion: High Costs And Price Hikes Are Reasons To Avoid This Pet Insurer
Summary Trupanion's Q3'24 revenue grew 15% YoY to $327.5M, driven mainly by price hikes, but EPS missed estimates by $0.46. Subscription adjusted operating income surged 66% to $30.8M, improving margins, but new pet growth deceleration raises concerns. Expansion into Germany and Switzerland offers growth opportunities, but North American profitability and competitive pressures remain critical challenges. Trupanion faces risks from unsustainable price hikes, growing veterinary inflation, and higher acquisition costs. Its strategy of ramping up pet acquisition spending could pressure short-term profitability without guaranteeing long-term growth. Despite growth prospects in the pet insurance market, Trupanion’s high valuation, with an expected 7% revenue growth in 2025, makes it an expensive investment. Read the full article on Seeking AlphaArtículo de análisis • Oct 25
Revenues Tell The Story For Trupanion, Inc. (NASDAQ:TRUP) As Its Stock Soars 25%
Trupanion, Inc. ( NASDAQ:TRUP ) shares have continued their recent momentum with a 25% gain in the last month alone...Seeking Alpha • Sep 24
Trupanion: Great Business, But It Is Time To Cash Out (Rating Downgrade)
Summary Trupanion's stock surged over 60% since my June 2024 buy rating. Trupanion's Q2 results show strong revenue and subscription growth, with free cash flow turning positive, indicating a sustainable business model. Price hikes are essential due to rising veterinary costs and increasing anxiety claims in pets, which could impact long-term profitability if not managed. Shares are no longer a buy, and I reiterate my $40 price target with a hold rating now. Read the full article on Seeking AlphaArtículo de análisis • Aug 11
Trupanion, Inc. (NASDAQ:TRUP) Just Reported And Analysts Have Been Lifting Their Price Targets
It's been a pretty great week for Trupanion, Inc. ( NASDAQ:TRUP ) shareholders, with its shares surging 14% to US$38.30...Artículo de análisis • Jul 31
A Piece Of The Puzzle Missing From Trupanion, Inc.'s (NASDAQ:TRUP) 27% Share Price Climb
Trupanion, Inc. ( NASDAQ:TRUP ) shares have continued their recent momentum with a 27% gain in the last month alone...Seeking Alpha • Jun 13
Trupanion: Growth First, Profitability Second
Summary Trupanion is a global pet insurance company. Trupanion may be headed for profitability, with the new CEO emphasizing efficiency and free cash flow. The company offers pet insurance through subscriptions, focusing on growth first and profits later. Shares are a buy with a price target of $40. Read the full article on Seeking AlphaArtículo de análisis • Feb 16
A Piece Of The Puzzle Missing From Trupanion, Inc.'s (NASDAQ:TRUP) 27% Share Price Climb
Despite an already strong run, Trupanion, Inc. ( NASDAQ:TRUP ) shares have been powering on, with a gain of 27% in the...Seeking Alpha • Feb 02
Trupanion: After All This Time, No Profits
Summary Pet insurance industry has seen significant growth due to the rising trend of millennials and Gen Z preferring pets over having children. Trupanion, a pet insurance company, has experienced wild revenue growth but struggles with increasing costs and negative margins. The company's balance sheet is not heavily burdened with liabilities, but profitability hinges on stabilizing operating expenses and addressing veterinary price hikes. Read the full article on Seeking AlphaArtículo de análisis • Dec 18
A Piece Of The Puzzle Missing From Trupanion, Inc.'s (NASDAQ:TRUP) 27% Share Price Climb
Trupanion, Inc. ( NASDAQ:TRUP ) shares have had a really impressive month, gaining 27% after a shaky period beforehand...Artículo de análisis • Apr 18
What You Can Learn From Trupanion, Inc.'s (NASDAQ:TRUP) P/SAfter Its 35% Share Price Crash
The Trupanion, Inc. ( NASDAQ:TRUP ) share price has fared very poorly over the last month, falling by a substantial...Rentabilidad de los accionistas
| TRUP | US Insurance | Mercado US | |
|---|---|---|---|
| 7D | 7.7% | 4.7% | -2.6% |
| 1Y | -54.7% | -1.1% | 20.0% |
Rentabilidad vs. Industria: Los resultados de TRUP fueron inferiores a los de la industria US Insurance, que obtuvo un rendimiento del -1.1% el año pasado.
Rentabilidad vs. Mercado: TRUP obtuvo unos resultados inferiores a los del mercado US, que fueron del 20% el año pasado.
Volatilidad de los precios
| TRUP volatility | |
|---|---|
| TRUP Average Weekly Movement | 6.1% |
| Insurance Industry Average Movement | 4.2% |
| Market Average Movement | 7.3% |
| 10% most volatile stocks in US Market | 16.7% |
| 10% least volatile stocks in US Market | 3.2% |
Precio estable de las acciones: TRUP no ha tenido una volatilidad de precios significativa en los últimos 3 meses en comparación con el mercado US.
Volatilidad a lo largo del tiempo: La volatilidad semanal de TRUP (6%) se ha mantenido estable durante el año pasado.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| 2006 | 1,121 | Margi Tooth | www.trupanion.com |
Trupanion, Inc. junto con sus filiales, ofrece seguros médicos para perros y gatos por suscripción en Estados Unidos, Canadá, Europa continental y Australia. La empresa opera en dos segmentos: negocio de suscripción y otros negocios. Presta servicios a propietarios de mascotas y veterinarios.
Resumen de fundamentos de Trupanion, Inc.
| Estadísticas fundamentales de TRUP | |
|---|---|
| Capitalización bursátil | US$1.05b |
| Beneficios(TTM) | US$25.80m |
| Ingresos (TTM) | US$1.48b |
42.9x
Ratio precio-beneficio (PE)0.7x
Ratio precio-ventas (PS)¿Está TRUP sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de TRUP | |
|---|---|
| Ingresos | US$1.48b |
| Coste de los ingresos | US$1.15b |
| Beneficio bruto | US$330.92m |
| Otros gastos | US$305.12m |
| Beneficios | US$25.80m |
Últimos beneficios comunicados
Mar 31, 2026
Próxima fecha de beneficios
n/a
| Beneficios por acción (BPA) | 0.59 |
| Margen bruto | 22.34% |
| Margen de beneficio neto | 1.74% |
| Ratio deuda/patrimonio | 27.7% |
¿Cómo se ha desempeñado TRUP a largo plazo?
Ver rendimiento histórico y comparativaAnálisis de la empresa y estado de los datos financieros
| Datos | Última actualización (huso horario UTC) |
|---|---|
| Análisis de la empresa | 2026/06/26 11:43 |
| Precio de las acciones al final del día | 2026/06/26 00:00 |
| Beneficios | 2026/03/31 |
| Ingresos anuales | 2025/12/31 |
Fuentes de datos
Los datos utilizados en nuestro análisis de empresas proceden de S&P Global Market Intelligence LLC. Los siguientes datos se utilizan en nuestro modelo de análisis para generar este informe. Los datos están normalizados, lo que puede introducir un retraso desde que la fuente está disponible.
| Paquete | Datos | Marco temporal | Ejemplo Fuente EE.UU. * |
|---|---|---|---|
| Finanzas de la empresa | 10 años |
| |
| Estimaciones del consenso de analistas | +3 años |
|
|
| Precios de mercado | 30 años |
| |
| Propiedad | 10 años |
| |
| Gestión | 10 años |
| |
| Principales avances | 10 años |
|
* Ejemplo para valores de EE.UU., para no EE.UU. se utilizan formularios y fuentes normativas equivalentes.
A menos que se especifique lo contrario, todos los datos financieros se basan en un periodo anual, pero se actualizan trimestralmente. Esto se conoce como datos de los últimos doce meses (TTM) o de los últimos doce meses (LTM). Más información.
Modelo de análisis y copo de nieve
Los detalles del modelo de análisis utilizado para generar este informe están disponibles en nuestra página de Github, también contamos con guías sobre cómo utilizar nuestros informes y tutoriales en Youtube.
Conozca al equipo de talla mundial que diseñó y construyó el modelo de análisis Simply Wall St.
Métricas industriales y sectoriales
Simply Wall St calcula cada 6 horas nuestras métricas sectoriales y de sección. Los detalles de nuestro proceso están disponibles en Github.
Fuentes analistas
Trupanion, Inc. está cubierta por 16 analistas. 5 de esos analistas presentaron las estimaciones de ingresos o ganancias utilizadas como datos para nuestro informe. Las estimaciones de los analistas se actualizan a lo largo del día.
| Analista | Institución |
|---|---|
| Christopher Merwin | Barclays |
| Joshua Shanker | BofA Global Research |
| Ryan Tunis | Cantor Fitzgerald & Co. |